世界の中枢神経系（CNS）障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Central Nervous System Disorders Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1229 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、中枢神経系（CNS）障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（うつ病、MS、双極性障害、統合失調症、癲癇、AD、パーキンソン病、その他）、用途別市場規模（臨床、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・中枢神経系（CNS）障害治療の市場動向 ・企業の競争状況、市場シェア ・中枢神経系（CNS）障害治療の種類別市場規模（うつ病、MS、双極性障害、統合失調症、癲癇、AD、パーキンソン病、その他） ・中枢神経系（CNS）障害治療の用途別市場規模（臨床、病院） ・中枢神経系（CNS）障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・中枢神経系（CNS）障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・中枢神経系（CNS）障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・中枢神経系（CNS）障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・中枢神経系（CNS）障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、GlaxoSmithKline、Janssen Pharmaceuticals、Novartis、Pfizer） ・結論

Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
Depression is the dominated market of CNS Disorders Therapeutics

Market Analysis and Insights: Global Central Nervous System Disorders Therapeutics Market
The global Central Nervous System Disorders Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of 3.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Central Nervous System Disorders Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Central Nervous System Disorders Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Central Nervous System Disorders Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Central Nervous System Disorders Therapeutics market.

Global Central Nervous System Disorders Therapeutics Scope and Market Size
Central Nervous System Disorders Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Central Nervous System Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Depression
MS
bipolar disorder
schizophrenia
epilepsy
AD
Parkinson’ s
others

Segment by Application
Clinicals
Hospitials

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Depression
1.2.3 MS
1.2.4 bipolar disorder
1.2.5 schizophrenia
1.2.6 epilepsy
1.2.7 AD
1.2.8 Parkinson’ s
1.2.9 others
1.3 Market by Application
1.3.1 Global Central Nervous System Disorders Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinicals
1.3.3 Hospitials
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Central Nervous System Disorders Therapeutics Market Perspective (2016-2027)
2.2 Central Nervous System Disorders Therapeutics Growth Trends by Regions
2.2.1 Central Nervous System Disorders Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Central Nervous System Disorders Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Central Nervous System Disorders Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Central Nervous System Disorders Therapeutics Industry Dynamic
2.3.1 Central Nervous System Disorders Therapeutics Market Trends
2.3.2 Central Nervous System Disorders Therapeutics Market Drivers
2.3.3 Central Nervous System Disorders Therapeutics Market Challenges
2.3.4 Central Nervous System Disorders Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System Disorders Therapeutics Players by Revenue
3.1.1 Global Top Central Nervous System Disorders Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Central Nervous System Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System Disorders Therapeutics Revenue
3.4 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Disorders Therapeutics Revenue in 2020
3.5 Central Nervous System Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Central Nervous System Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Central Nervous System Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Central Nervous System Disorders Therapeutics Breakdown Data by Type
4.1 Global Central Nervous System Disorders Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Type (2022-2027)

5 Central Nervous System Disorders Therapeutics Breakdown Data by Application
5.1 Global Central Nervous System Disorders Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Central Nervous System Disorders Therapeutics Market Size (2016-2027)
6.2 North America Central Nervous System Disorders Therapeutics Market Size by Type
6.2.1 North America Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Central Nervous System Disorders Therapeutics Market Size by Type (2016-2027)
6.3 North America Central Nervous System Disorders Therapeutics Market Size by Application
6.3.1 North America Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Central Nervous System Disorders Therapeutics Market Size by Application (2016-2027)
6.4 North America Central Nervous System Disorders Therapeutics Market Size by Country
6.4.1 North America Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Central Nervous System Disorders Therapeutics Market Size (2016-2027)
7.2 Europe Central Nervous System Disorders Therapeutics Market Size by Type
7.2.1 Europe Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Central Nervous System Disorders Therapeutics Market Size by Type (2016-2027)
7.3 Europe Central Nervous System Disorders Therapeutics Market Size by Application
7.3.1 Europe Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Central Nervous System Disorders Therapeutics Market Size by Application (2016-2027)
7.4 Europe Central Nervous System Disorders Therapeutics Market Size by Country
7.4.1 Europe Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Type
8.2.1 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Application
8.3.1 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region
8.4.1 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Central Nervous System Disorders Therapeutics Market Size (2016-2027)
9.2 Latin America Central Nervous System Disorders Therapeutics Market Size by Type
9.2.1 Latin America Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Central Nervous System Disorders Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Central Nervous System Disorders Therapeutics Market Size by Application
9.3.1 Latin America Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Central Nervous System Disorders Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Central Nervous System Disorders Therapeutics Market Size by Country
9.4.1 Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Type
10.2.1 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application
10.3.1 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country
10.4.1 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Central Nervous System Disorders Therapeutics Introduction
11.1.4 Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Central Nervous System Disorders Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Details
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Central Nervous System Disorders Therapeutics Introduction
11.4.4 Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Central Nervous System Disorders Therapeutics Introduction
11.5.4 Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Depression
Table 3. Key Players of MS
Table 4. Key Players of bipolar disorder
Table 5. Key Players of schizophrenia
Table 6. Key Players of epilepsy
Table 7. Key Players of AD
Table 8. Key Players of Parkinson' s
Table 9. Key Players of others
Table 10. Global Central Nervous System Disorders Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Central Nervous System Disorders Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Central Nervous System Disorders Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Central Nervous System Disorders Therapeutics Market Share by Regions (2016-2021)
Table 14. Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Central Nervous System Disorders Therapeutics Market Share by Regions (2022-2027)
Table 16. Central Nervous System Disorders Therapeutics Market Trends
Table 17. Central Nervous System Disorders Therapeutics Market Drivers
Table 18. Central Nervous System Disorders Therapeutics Market Challenges
Table 19. Central Nervous System Disorders Therapeutics Market Restraints
Table 20. Global Central Nervous System Disorders Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Central Nervous System Disorders Therapeutics Market Share by Players (2016-2021)
Table 22. Global Top Central Nervous System Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System Disorders Therapeutics as of 2020)
Table 23. Ranking of Global Top Central Nervous System Disorders Therapeutics Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Central Nervous System Disorders Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Central Nervous System Disorders Therapeutics Product Solution and Service
Table 27. Date of Enter into Central Nervous System Disorders Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Table 31. Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Central Nervous System Disorders Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2016-2021)
Table 35. Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Central Nervous System Disorders Therapeutics Product
Table 70. Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Central Nervous System Disorders Therapeutics Product
Table 75. GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Janssen Pharmaceuticals Company Details
Table 78. Janssen Pharmaceuticals Business Overview
Table 79. Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Product
Table 80. Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Janssen Pharmaceuticals Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Central Nervous System Disorders Therapeutics Product
Table 85. Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Central Nervous System Disorders Therapeutics Product
Table 90. Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System Disorders Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Depression Features
Figure 3. MS Features
Figure 4. bipolar disorder Features
Figure 5. schizophrenia Features
Figure 6. epilepsy Features
Figure 7. AD Features
Figure 8. Parkinson' s Features
Figure 9. others Features
Figure 10. Global Central Nervous System Disorders Therapeutics Market Share by Application: 2020 VS 2027
Figure 11. Clinicals Case Studies
Figure 12. Hospitials Case Studies
Figure 13. Central Nervous System Disorders Therapeutics Report Years Considered
Figure 14. Global Central Nervous System Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Central Nervous System Disorders Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Central Nervous System Disorders Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Central Nervous System Disorders Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Central Nervous System Disorders Therapeutics Market Share by Players in 2020
Figure 19. Global Top Central Nervous System Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System Disorders Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Central Nervous System Disorders Therapeutics Revenue in 2020
Figure 21. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Central Nervous System Disorders Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Central Nervous System Disorders Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Central Nervous System Disorders Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Central Nervous System Disorders Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Central Nervous System Disorders Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Central Nervous System Disorders Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Central Nervous System Disorders Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Central Nervous System Disorders Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Central Nervous System Disorders Therapeutics Market Share by Region (2016-2027)
Figure 43. China Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Central Nervous System Disorders Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Central Nervous System Disorders Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Central Nervous System Disorders Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Central Nervous System Disorders Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Central Nervous System Disorders Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Central Nervous System Disorders Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Central Nervous System Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Eli Lilly Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2016-2021)
Figure 64. Janssen Pharmaceuticals Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---